Nf-Kappa B Inhibitors As A Novel Therapeutic Agent In The Acute Phase Of Kawasaki Disease
Circulation（2018）
Abstract
Introduction: Kawasaki disease (KD), which is the most common multisystem vasculitis with unknown causes in childhood, causes coronary artery aneurysms (CAAs). Infliximab (IFX), anti-human TNF-α mo...
MoreTranslated text
Key words
kawasaki disease,novel therapeutic agent,inhibitors,nf-kappa
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined